Carbohydrate antigen 125 (CA 125), CA 15-3, CA 19-9,
etc. are currently widely used clinical glycoprotein tumor markers.
CD BioGlyco is a leader in the field of glycoproteins, dedicated to providing customers with a wide range of natural and recombinant CA antigens for cancer research.
